2000
DOI: 10.1038/sj.gt.3301258
|View full text |Cite
|
Sign up to set email alerts
|

A multi-domain protein for β1 integrin-targeted DNA delivery

Abstract: The development of effective receptor-targeted nonviral vectors for use in vivo is complicated by a number of technical problems. One of these is the low efficiency of the conjugation procedures used to couple protein ligands to the DNA condensing carrier molecules. We have made and characterized a multi-domain protein (SPKR) 4 inv, that is designed to target plasmid DNA to ␤ 1 integrins in remodeling tissue. It contains a nonspecific DNA-binding domain (SPKR) 4 , a rigid ␣-helical linker, and the C-terminal ␤… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2001
2001
2013
2013

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 38 publications
0
11
0
Order By: Relevance
“…[5][6][7][8][9] However, current gene therapy techniques have the need for vehicles that can provide selective, efficient and targeted gene delivery in a nontoxic, noninflammatory and nonimmunogenic manner. [10][11][12][13][14][15][16][17][18][19] Our vehicle for plasmid DNA transfection is a commercially available two component fibrin glue, which is known to be well degradated by the organism, not immunogenic, and causing no inflammatory response to the tissue.…”
Section: Introductionmentioning
confidence: 99%
“…[5][6][7][8][9] However, current gene therapy techniques have the need for vehicles that can provide selective, efficient and targeted gene delivery in a nontoxic, noninflammatory and nonimmunogenic manner. [10][11][12][13][14][15][16][17][18][19] Our vehicle for plasmid DNA transfection is a commercially available two component fibrin glue, which is known to be well degradated by the organism, not immunogenic, and causing no inflammatory response to the tissue.…”
Section: Introductionmentioning
confidence: 99%
“…This has important consequences for the engineering of tissue supports that, to date, generally involves RGD conjugation to polymers in a random distribution or non-specific adsorption of collagen or fibronectin (Rowley et al 1999;Tan et al 2001;Yang et al 2001). Similarly, recombinant proteins and polypeptides binding integrin for targeted gene delivery via receptor-mediated endocytosis have focussed on monovalent RGD and invasin ligands, extended by cationic polypeptides binding DNA (Harbottle et al 1998;Fortunati et al 2000;Kunath et al 2003). As our understanding of integrin-ligand binding advances, it would appear timely to explore alternative polypeptide templates facilitating a clustered organisation of RGD ligands.…”
Section: Introductionmentioning
confidence: 99%
“…Specific receptor clustering seems to be required for other bacterial-ligand receptor interactions (4, 10); therefore, our strategy has the potential to apply to the functional analysis for other bacterial entries. Furthermore, our system is able to be adapted to molecular delivery to mammalian epithelial cells expressing integrin β1, which is a recent topic of therapeutic utilization of bacterial proteins (5,6,8,9). INTRACELLULAR …”
Section: Discussionmentioning
confidence: 99%